Total Payments
$801,349
2024 Payments
$97,956
Companies
56
Transactions
2,160
Medicare Patients
2,354
Medicare Billing
$538,714
Payment Breakdown by Category
Other$591,928 (73.9%)
Travel$93,181 (11.6%)
Consulting$71,587 (8.9%)
Food & Beverage$44,079 (5.5%)
Education$572.98 (0.1%)
Gifts$1.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $590,308 | 252 | 73.7% |
| Travel and Lodging | $93,181 | 662 | 11.6% |
| Consulting Fee | $71,587 | 38 | 8.9% |
| Food and Beverage | $44,079 | 1,182 | 5.5% |
| Honoraria | $1,620 | 2 | 0.2% |
| Education | $572.98 | 23 | 0.1% |
| Gift | $1.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $163,177 | 346 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $157,312 | 355 | $0 (2024) |
| Vifor Pharma, Inc. | $148,345 | 288 | $0 (2024) |
| GlaxoSmithKline, LLC. | $113,449 | 138 | $0 (2024) |
| Daiichi Sankyo Inc. | $99,326 | 220 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $41,902 | 80 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $33,690 | 62 | $0 (2021) |
| Boehringer Ingelheim International GmbH | $11,025 | 6 | $0 (2023) |
| Travere Therapeutics, Inc. | $5,868 | 30 | $0 (2024) |
| Janssen Global Services, LLC | $5,405 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97,956 | 279 | AstraZeneca Pharmaceuticals LP ($28,001) |
| 2023 | $173,408 | 406 | AstraZeneca Pharmaceuticals LP ($60,129) |
| 2022 | $222,922 | 450 | Vifor Pharma, Inc. ($94,325) |
| 2021 | $76,676 | 272 | Vifor Pharma, Inc. ($30,154) |
| 2020 | $49,931 | 171 | Relypsa, Inc. ($32,295) |
| 2019 | $109,412 | 298 | Relypsa, Inc. ($64,923) |
| 2018 | $53,160 | 178 | Relypsa, Inc. ($49,765) |
| 2017 | $17,885 | 106 | Relypsa, Inc. ($16,194) |
All Payment Transactions
2,160 individual payment records from CMS Open Payments — Page 1 of 87
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Catheter Lock Solution | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEPHROLOGY | ||||||
| 12/17/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $38.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $43.69 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEPHROLOGY | ||||||
| 12/06/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Cardio-renal | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardio-renal | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $14.74 | General |
| Category: Cardio-renal | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $2.92 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEPHROLOGY | ||||||
| 11/21/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $75.86 | General |
| Category: Nephrology | ||||||
| 11/20/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Catheter Lock Solution | ||||||
| 11/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 579 | 1,465 | $178,138 | $119,614 |
| 2022 | 10 | 613 | 1,505 | $185,378 | $126,061 |
| 2021 | 8 | 599 | 1,738 | $210,285 | $145,033 |
| 2020 | 8 | 563 | 1,795 | $220,198 | $148,007 |
Total Patients
2,354
Total Services
6,503
Medicare Billing
$538,714
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 776 | $57,680 | $45,135 | 78.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 263 | $44,710 | $24,661 | 55.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 71 | $19,597 | $12,140 | 62.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 50 | $15,089 | $11,321 | 75.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 105 | $14,651 | $10,491 | 71.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 121 | $12,981 | $10,042 | 77.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $6,800 | $3,327 | 48.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 28 | 39 | $6,630 | $2,497 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 148 | 697 | $51,742 | $38,987 | 75.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 285 | $48,450 | $26,125 | 53.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 85 | $25,651 | $20,016 | 78.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 193 | $20,469 | $15,647 | 76.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 111 | 119 | $16,976 | $12,437 | 73.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 30 | $6,193 | $4,895 | 79.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 46 | 46 | $7,820 | $3,801 | 48.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 27 | $4,590 | $1,967 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,002 | $1,451 | 72.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,485 | $735.23 | 49.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 166 | 917 | $68,148 | $52,600 | 77.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 284 | $48,280 | $25,895 | 53.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 93 | $26,550 | $20,249 | 76.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 179 | $19,128 | $14,754 | 77.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 120 | 139 | $19,961 | $14,726 | 73.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 22 | 47 | $13,367 | $8,085 | 60.5% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 16 | 42 | $8,562 | $5,793 | 67.7% |
About Dr. Gates Colbert, M.D
Dr. Gates Colbert, M.D is a Internal Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1992017545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gates Colbert, M.D has received a total of $801,349 in payments from pharmaceutical and medical device companies, with $97,956 received in 2024. These payments were reported across 2,160 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($590,308).
As a Medicare-enrolled provider, Colbert has provided services to 2,354 Medicare beneficiaries, totaling 6,503 services with total Medicare billing of $538,714. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Dallas, TX
- Active Since 07/12/2010
- Last Updated 11/04/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992017545
Products in Payments
- Veltassa (Drug) $226,793
- FARXIGA (Drug) $150,017
- INJECTAFER (Drug) $99,326
- BENLYSTA (Biological) $94,683
- Kerendia (Drug) $41,902
- INVOKANA (Drug) $33,386
- Korsuva (Drug) $7,515
- JESDUVROQ (Drug) $5,791
- GIAPREZA (Drug) $3,000
- TARPEYO (Drug) $2,542
- SPEVIGO (Drug) $2,250
- LOKELMA (Drug) $2,226
- ACTHAR (Biological) $1,433
- JYNARQUE (Drug) $1,133
- RAYALDEE (Drug) $867.11
- Parsabiv (Drug) $866.88
- Rayaldee (Drug) $607.33
- ULTOMIRIS (Biological) $586.88
- KRYSTEXXA (Biological) $582.67
- Velphoro (Drug) $480.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Internal Medicine $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Internal Medicine $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Internal Medicine $813,092
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379
Internal Medicine $743,379
Dr. Edward Pearson, Md, MD
Internal Medicine — Payments: $728,183
Internal Medicine $728,183